Equibles does not estimate personal net worth.
Get an email with a short summary when Tonix Pharmaceuticals Holding Corp. publishes a filing, an earnings call transcript or a press release.
Get TNXP alertsBradley Saenger is recorded as CFO at Tonix Pharmaceuticals Holding Corp. (TNXP). The proxy statement of Tonix Pharmaceuticals Holding Corp. reports total compensation of $1,143,513 for Bradley Saenger in fiscal 2025, including a base salary of $502,944. Disclosed compensation is on record for 8 fiscal years. Bradley Saenger has spoken on 1 earnings call across 1 company, most recently for Tonix Pharmaceuticals Holding Corp. on August 10, 2026. Tonix Pharmaceuticals Holding Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tonix Pharmaceuticals Holding Corp. includes Seth Lederman (CEO and Board Member), Siobhan Fogarty (CTO), Adeoye Olukotun (Board Member) and 7 others.
“On slide 8, I will review financial results for the second quarter ended June 30th, 2026. Net product revenue for the second quarter of 2026 was approximately $13.5 million, which consists of approximately $11 million from Tonmaya and $2.5 million from Zembray, Simtouch and Tisimra, which are our migraine products.”
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $502,944 | $1,143,513 |
| 2024 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $483,600 | $849,981 |
| 2023 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $465,000 | $904,913 |
| 2022 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $445,400 | $1,236,430 |
| 2021 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $425,000 | $1,769,885 |
| 2020 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $404,250 | $1,091,808 |
| 2019 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $385,000 | $578,112 |
| 2018 | Tonix Pharmaceuticals Holding Corp. (TNXP) | Chief Financial Officer | $335,000 | $616,235 |
